Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Robb M. Stewart Eupraxia Pharmaceuticals has initiated the second cohort for its early-stage trial in eosinophilic esophagitis as it continues to make...
Health-care companies fell as traders digested the mixed implications of blockbuster obesity drugs. Shares of Danish obesity-drug maker Novo Nordisk rallied...
By Ben Glickman Ventyx released results from its trial of VTX002 in the treatment of ulcerative colitis. The company found that its treatment had a...
By Colin Kellaher Merck & Co. on Tuesday said a Phase 3 study of its Keytruda cancer drug met the second of its dual primary endpoints as a perioperative...
Keytruda showed a 'statistically significant and clinically meaningful improvement' in overall survival in a late-stage trial.